Richard L. Rudolph, MD
- 3Articles
- 8.7KReads1
- 1998–2004Active
- 8Collaborators
About
Richard L. Rudolph, MD, has contributed to research on major depressive disorder, focusing on the efficacy and dosing of venlafaxine in treating and preventing recurrent depression. His publications include randomized, placebo-controlled trials and discussions on treatment goals such as response, remission, and recovery in antidepressant therapy. His work, published between 1998 and 2004, often involved collaboration with colleagues including Richard Entsuah and Karl Rickels.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
